Drugs used in the treatment of migraine have been recently reported to be highly associated with the occurrence of clinically significant drug-drug interactions (DDIs).
Choosing the safest acute combination therapy during prophylactic treatment. pharmacokinetic and pharmacodynamic considerations / Lionetto, Luana; Martelletti, Paolo. - In: THE JOURNAL OF HEADACHE AND PAIN. - ISSN 1129-2369. - ELETTRONICO. - 16:Suppl 1(2015), pp. 1-1. [10.1186/1129-2377-16-S1-A36]
Choosing the safest acute combination therapy during prophylactic treatment. pharmacokinetic and pharmacodynamic considerations
MARTELLETTI, Paolo
2015
Abstract
Drugs used in the treatment of migraine have been recently reported to be highly associated with the occurrence of clinically significant drug-drug interactions (DDIs).File allegati a questo prodotto
| File | Dimensione | Formato | |
|---|---|---|---|
|
Lionetto_Choosing_2015.pdf
accesso aperto
Note: article
Tipologia:
Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
192.85 kB
Formato
Adobe PDF
|
192.85 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
